Mercator Medical S.A. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was PLN 121.49 million compared to PLN 149.23 million a year ago. Revenue was PLN 136.73 million compared to PLN 152.42 million a year ago. Net income was PLN 9.57 million compared to net loss of PLN 11.12 million a year ago. Basic earnings per share from continuing operations was PLN 1 compared to basic loss per share from continuing operations of PLN 1.14 a year ago. Diluted earnings per share from continuing operations was PLN 1 compared to diluted loss per share from continuing operations of PLN 1.14 a year ago.
For the six months, sales was PLN 234.25 million compared to PLN 286.08 million a year ago. Revenue was PLN 254.99 million compared to PLN 319.92 million a year ago. Net loss was PLN 8.13 million compared to PLN 4.19 million a year ago. Basic loss per share from continuing operations was PLN 0.84 compared to PLN 0.43 a year ago. Diluted loss per share from continuing operations was PLN 0.84 compared to PLN 0.43 a year ago.